Ben Andrews

Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor β1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression

M. Kattan, T. Wheeler, S. Shariat, 2004, Clinical Cancer Research.

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Michael W Kattan, Kazumasa Matsumoto, M. Kattan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma

M W Kattan, B Andrews, M. Kattan, 2001, Cancer.

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

T. Wheeler, S. Shariat, S. Lerner, 2003, Urology.

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

M. Kattan, T. Wheeler, S. Shariat, 2001, Urology.

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.

T. Wheeler, S. Shariat, S. Lerner, 2002, The Journal of urology.